Echocardiographic assessment of left ventricular (LV) diastolic function is an integral part of
the routine evaluation of patients presenting with symptoms of dyspnea or heart failure. The …

Highlights•The LA is emerging as a biomarker for evaluation of diastolic dysfunction, AF, and
HFpEF.•LA size, although routinely evaluated by 2DE, may be more accurately evaluated by …

Cirrhotic cardiomyopathy (CCM) is cardiac dysfunction in patients with end‐stage liver
disease in the absence of prior heart disease. First defined in 2005 during the World …

The author examines the ability of left atrial size and function to predict cardiovascular
outcomes. Data are sufficient to recommend evaluation of left atrial volume in certain …

Left ventricular ejection fraction (LVEF) has been the central parameter used for diagnosis
and management in patients with heart failure. A good predictor of adverse outcomes in …

Context Vitamin D is associated with decreased cardiovascular-related morbidity and
mortality, possibly by modifying cardiac structure and function, yet firm evidence for either …

Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are obesity‐related
conditions with high cardiovascular mortality. Whether NAFLD is independently associated …

Aims Diagnosis and risk stratification of patients with heart failure remain a challenge. The
small non‐coding RNAs known as microRNAs regulate gene expression and seem to play …

Background—Cardiac resynchronization therapy (CRT) plus implantation of an implantable
cardioverter defibrillator (ICD) reduced the risk of death or heart failure event in patients with …

The left atrium is a dynamic chamber with peculiar characteristics. Stressors and disease
mechanisms may deeply modify its structure and function, leading to left atrial remodelling …